End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.55 TWD | 0.00% | +1.15% | +2.33% |
Business Summary
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Generic Drugs
96.5
%
| 4,238 | 96.6 % | 4,961 | 96.5 % | +17.05% |
Active Pharmaceutical Ingredients
3.5
%
| 148 | 3.4 % | 180 | 3.5 % | +21.37% |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
85.0
%
| 3,876 | 88.4 % | 4,368 | 85.0 % | +12.69% |
China
10.4
%
| 272 | 6.2 % | 534 | 10.4 % | +96.52% |
Others
1.2
%
| 70 | 1.6 % | 61 | 1.2 % | -13.28% |
Thailand
1.1
%
| 40 | 0.9 % | 55 | 1.1 % | +37.79% |
Singapore
0.8
%
| - | - | 42 | 0.8 % | - |
Malaysia
0.7
%
| 31 | 0.7 % | 36 | 0.7 % | +18.54% |
United States
0.6
%
| 63 | 1.4 % | 29 | 0.6 % | -54.12% |
Canada
0.3
%
| 35 | 0.8 % | 15 | 0.3 % | -55.68% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chih Hui Lin
CEO | Chief Executive Officer | - | 70-08-24 |
Hung Chin Pai
DFI | Director of Finance/CFO | - | 01-03-31 |
Sheng Jen Yang
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chih Hui Lin
CEO | Chief Executive Officer | - | 70-08-24 |
Wan Ju Liao
BRD | Director/Board Member | 41 | 19-05-23 |
Li Wen Huang
BRD | Director/Board Member | 51 | 19-05-23 |
Yu Peng Chang
BRD | Director/Board Member | 43 | 19-05-23 |
Sheng Jen Yang
PRN | Corporate Officer/Principal | - | - |
Te Chuan Fan
BRD | Director/Board Member | 41 | 10-06-14 |
Hsiang Lang Liu
BRD | Director/Board Member | 42 | 03-01-23 |
Xiu Mei Lin
BRD | Director/Board Member | 42 | 19-05-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 415,268,897 | 320,998,897 ( 77.30 %) | 19,373,000 ( 4.665 %) | 77.30 % |
Company contact information
Sector
Sales per Business
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.33% | 466M | |
+29.98% | 682B | |
+31.81% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.26% | 240B | |
+9.34% | 209B | |
-9.28% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- 4114 Stock
- Company Synmosa Biopharma Corporation